Effectiveness assessment of non-pharmaceutical interventions: lessons learned from the COVID-19 pandemic.

A Lison; N Banholzer; M Sharma; S Mindermann; HJT Unwin; S Mishra; T Stadler; S Bhatt; NM Ferguson; J Brauner; W Vach

doi:10.1016/S2468-2667(23)00046-4

Effectiveness assessment of non-pharmaceutical interventions: lessons learned from the COVID-19 pandemic.

A Lison, N Banholzer, M Sharma, S Mindermann, HJT Unwin, S Mishra, T Stadler, S Bhatt^*, NM Ferguson, J Brauner, W Vach

^*Corresponding author for this work

Research output: Contribution to journal › Article (Academic Journal) › peer-review

32 Citations (Scopus)

Abstract

Effectiveness of non-pharmaceutical interventions (NPIs), such as school closures and stay-at-home orders, during the COVID-19 pandemic has been assessed in many studies. Such assessments can inform public health policies and contribute to evidence-based choices of NPIs during subsequent waves or future epidemics. However, methodological issues and no standardised assessment practices have restricted the practical value of the existing evidence. Here, we present and discuss lessons learned from the COVID-19 pandemic and make recommendations for standardising and improving assessment, data collection, and modelling. These recommendations could contribute to reliable and policy-relevant assessments of the effectiveness of NPIs during future epidemics.

Original language	English
Pages (from-to)	e311-e317
Journal	Lancet Public Health
Volume	8
Issue number	4
Early online date	23 Mar 2023
DOIs	https://doi.org/10.1016/S2468-2667(23)00046-4
Publication status	Published - 1 Apr 2023

Bibliographical note

Funding Information:
NMF, HJTU, and SB acknowledge funding from the UK Research and Innovation Medical Research Council (Centre for Global Infectious Disease Analysis: MR/R015600/1). NMF and SB acknowledge funding from the National Institute for Health Research (NIHR) Health Protection Unit in Modelling and Health Economics (NIHR200908) and philanthropic funding from Community Jameel. SB received support from the Novo Nordisk Foundation via The Novo Nordisk Young Investigator Award (NNF20OC0059309), from the Danish National Research Foundation via a chair position, and from The Eric and Wendy Schmidt Fund For Strategic Innovation via the Schmidt Polymath Award (G-22-63345). MS and JB were funded by the Engineering and Physical Sciences Research Council Centre for Doctoral Training in Autonomous Intelligent Machines and Systems (EP/S024050/1). JB was supported by Cancer Research UK. TS received funding from ETH Zürich.

Publisher Copyright:
© 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S2468-2667(23)00046-4Licence: CC BY

https://www.ncbi.nlm.nih.gov/pubmed/36965985

Handle.net

Persistent link

Cite this

@article{b4bc58673a3944f982964493fc586f82,

title = "Effectiveness assessment of non-pharmaceutical interventions: lessons learned from the COVID-19 pandemic.",

abstract = "Effectiveness of non-pharmaceutical interventions (NPIs), such as school closures and stay-at-home orders, during the COVID-19 pandemic has been assessed in many studies. Such assessments can inform public health policies and contribute to evidence-based choices of NPIs during subsequent waves or future epidemics. However, methodological issues and no standardised assessment practices have restricted the practical value of the existing evidence. Here, we present and discuss lessons learned from the COVID-19 pandemic and make recommendations for standardising and improving assessment, data collection, and modelling. These recommendations could contribute to reliable and policy-relevant assessments of the effectiveness of NPIs during future epidemics.",

author = "A Lison and N Banholzer and M Sharma and S Mindermann and HJT Unwin and S Mishra and T Stadler and S Bhatt and NM Ferguson and J Brauner and W Vach",

note = "Funding Information: NMF, HJTU, and SB acknowledge funding from the UK Research and Innovation Medical Research Council (Centre for Global Infectious Disease Analysis: MR/R015600/1). NMF and SB acknowledge funding from the National Institute for Health Research (NIHR) Health Protection Unit in Modelling and Health Economics (NIHR200908) and philanthropic funding from Community Jameel. SB received support from the Novo Nordisk Foundation via The Novo Nordisk Young Investigator Award (NNF20OC0059309), from the Danish National Research Foundation via a chair position, and from The Eric and Wendy Schmidt Fund For Strategic Innovation via the Schmidt Polymath Award (G-22-63345). MS and JB were funded by the Engineering and Physical Sciences Research Council Centre for Doctoral Training in Autonomous Intelligent Machines and Systems (EP/S024050/1). JB was supported by Cancer Research UK. TS received funding from ETH Z{\"u}rich. Publisher Copyright: {\textcopyright} 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.",

year = "2023",

month = apr,

day = "1",

doi = "10.1016/S2468-2667(23)00046-4",

language = "English",

volume = "8",

pages = "e311--e317",

journal = "Lancet Public Health",

issn = "2468-2667",

publisher = "Lancet Publishing Group",

number = "4",

}

TY - JOUR

T1 - Effectiveness assessment of non-pharmaceutical interventions

T2 - lessons learned from the COVID-19 pandemic.

AU - Lison, A

AU - Banholzer, N

AU - Sharma, M

AU - Mindermann, S

AU - Unwin, HJT

AU - Mishra, S

AU - Stadler, T

AU - Bhatt, S

AU - Ferguson, NM

AU - Brauner, J

AU - Vach, W

N1 - Funding Information: NMF, HJTU, and SB acknowledge funding from the UK Research and Innovation Medical Research Council (Centre for Global Infectious Disease Analysis: MR/R015600/1). NMF and SB acknowledge funding from the National Institute for Health Research (NIHR) Health Protection Unit in Modelling and Health Economics (NIHR200908) and philanthropic funding from Community Jameel. SB received support from the Novo Nordisk Foundation via The Novo Nordisk Young Investigator Award (NNF20OC0059309), from the Danish National Research Foundation via a chair position, and from The Eric and Wendy Schmidt Fund For Strategic Innovation via the Schmidt Polymath Award (G-22-63345). MS and JB were funded by the Engineering and Physical Sciences Research Council Centre for Doctoral Training in Autonomous Intelligent Machines and Systems (EP/S024050/1). JB was supported by Cancer Research UK. TS received funding from ETH Zürich. Publisher Copyright: © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.

PY - 2023/4/1

Y1 - 2023/4/1

N2 - Effectiveness of non-pharmaceutical interventions (NPIs), such as school closures and stay-at-home orders, during the COVID-19 pandemic has been assessed in many studies. Such assessments can inform public health policies and contribute to evidence-based choices of NPIs during subsequent waves or future epidemics. However, methodological issues and no standardised assessment practices have restricted the practical value of the existing evidence. Here, we present and discuss lessons learned from the COVID-19 pandemic and make recommendations for standardising and improving assessment, data collection, and modelling. These recommendations could contribute to reliable and policy-relevant assessments of the effectiveness of NPIs during future epidemics.

AB - Effectiveness of non-pharmaceutical interventions (NPIs), such as school closures and stay-at-home orders, during the COVID-19 pandemic has been assessed in many studies. Such assessments can inform public health policies and contribute to evidence-based choices of NPIs during subsequent waves or future epidemics. However, methodological issues and no standardised assessment practices have restricted the practical value of the existing evidence. Here, we present and discuss lessons learned from the COVID-19 pandemic and make recommendations for standardising and improving assessment, data collection, and modelling. These recommendations could contribute to reliable and policy-relevant assessments of the effectiveness of NPIs during future epidemics.

U2 - 10.1016/S2468-2667(23)00046-4

DO - 10.1016/S2468-2667(23)00046-4

M3 - Article (Academic Journal)

C2 - 36965985

SN - 2468-2667

VL - 8

SP - e311-e317

JO - Lancet Public Health

JF - Lancet Public Health

IS - 4

ER -

Effectiveness assessment of non-pharmaceutical interventions: lessons learned from the COVID-19 pandemic.

Abstract

Bibliographical note

UN SDGs

Access to Document

Handle.net

Fingerprint

Cite this